Related references
Note: Only part of the references are listed.Lower expression of CXCR4 in lymph node metastases than in primary breast cancers:: Potential regulation by ligand-dependent degradation and HIF-1α
Hyunsuk Shim et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2006)
Evaluation of HER-2/neu amplification and other biological markers as predictors of response to neoadjuvant anthracycline-based chemotherapy in primary breast cancer - The role of anthrocycline dose intensity
C Bozzetti et al.
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS (2006)
Changes of topoisomerase IIα expression in breast tumors after neoadjuvant chemotherapy predicts relapse-free survival
N Tinari et al.
CLINICAL CANCER RESEARCH (2006)
HER3 genomic gain and sensitivity to gefitinib in advanced non-small-cell lung cancer patients
F Cappuzzo et al.
BRITISH JOURNAL OF CANCER (2005)
Activation of chemokine receptor CXCR4 in malignant glioma cells promotes the production of vascular endothelial growth factor
SX Yang et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2005)
Changes in gene expression associated with response to neoadjuvant chemotherapy in breast cancer
J Hannemann et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Pathological and clinical response of a primary chemotherapy regimen combining vinorelbine, epirubicin, and paclitaxel as neoadjuvant treatment in patients with operable breast cancer
C Abrial et al.
ONCOLOGIST (2005)
Comparative value of tumour grade, hormonal receptors, Ki-67, HER-2 and topoisomerase II alpha status as predictive markers in breast cancer patients treated with neoadjuvant anthracycline-based chemotherapy
T Petit et al.
EUROPEAN JOURNAL OF CANCER (2004)
Serial topoisomerase II expression in primary breast cancer and response to neoadjuvant anthracycline-based chemotherapy
M Martin-Richard et al.
ONCOLOGY (2004)
The effect of neoadjuvant chemotherapy on estrogen and progesterone receptor expression and hormone receptor status in breast cancer
SH Lee et al.
AMERICAN JOURNAL OF SURGERY (2003)
Comparing fluorescence in situ hybridization and chromogenic in situ hybridization methods to determine the HER2/neu status in primary breast carcinoma using tissue microarray
K Park et al.
MODERN PATHOLOGY (2003)
Evaluation of HER-2/neu oncogene status in breast tumors on tissue microarrays
DH Zhang et al.
HUMAN PATHOLOGY (2003)
Correlation between HER-2 expression and response to neoadjuvant chemotherapy with 5-fluorouracil, doxorubicin, and cyclophosphamide in patients with breast carcinoma
F Zhang et al.
CANCER (2003)
Breast cancer response to neoadjuvant chemotherapy: predictive markers and relation with outcome
IF Faneyte et al.
BRITISH JOURNAL OF CANCER (2003)
Share Paper
